Lytix Biopharma

Norway
Tromsø, Troms, Norway, NO-9294

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$20.5M
Last funding
Post IPO Equity / $10.1M / 2024-12-16
Last equity funding
Post IPO Equity / $10.1M
Investors
9
Lead investors
1
Founders
1
Articles
61
Exited on
2021-07-18

Founders and investors

Founders

Oystein Rekdal

Lead investors

SkatteFUNN

Investors

Norinnova ForvaltningNorinnova InvestPrimaryBidSkatteFUNNSparebanken Nord-Norge